Verona Pharma PLC (VRNA)
12.00
-0.60
(-4.76%)
USD |
NASDAQ |
May 23, 16:00
12.00
0.00 (0.00%)
Pre-Market: 20:00
Verona Pharma Free Cash Flow: -58.07M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -58.07M |
December 31, 2023 | -50.22M |
September 30, 2023 | -47.56M |
June 30, 2023 | -52.93M |
March 31, 2023 | -51.16M |
December 31, 2022 | -59.89M |
September 30, 2022 | -69.48M |
June 30, 2022 | -28.57M |
March 31, 2022 | -29.23M |
December 31, 2021 | -33.27M |
September 30, 2021 | -34.75M |
June 30, 2021 | -67.62M |
March 31, 2021 | -50.48M |
Date | Value |
---|---|
December 31, 2020 | -45.16M |
September 30, 2020 | -37.70M |
June 30, 2020 | -36.16M |
March 31, 2020 | -43.20M |
December 31, 2019 | -42.92M |
September 30, 2019 | -37.58M |
June 30, 2019 | -30.01M |
March 31, 2019 | -27.33M |
December 31, 2018 | -23.32M |
September 30, 2018 | -24.19M |
June 30, 2018 | -33.86M |
March 31, 2018 | -32.71M |
December 31, 2017 | -28.26M |
Free Cash Flow Range, Past 5 Years
-69.48M
Minimum
Sep 2022
-28.57M
Maximum
Jun 2022
-45.30M
Average
-44.18M
Median
Free Cash Flow Benchmarks
Biodexa Pharmaceuticals Plc | -8.842M |
NuCana PLC | -28.30M |
TC BioPharm (Holdings) PLC | -15.84M |
Bicycle Therapeutics PLC | -85.93M |
Adaptimmune Therapeutics PLC | -138.26M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -13.61M |
Cash from Investing (Quarterly) | -0.016M |
Cash from Financing (Quarterly) | -3.123M |
Free Cash Flow Per Share (Quarterly) | -0.1688 |
Free Cash Flow Yield | -6.05% |